Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης [ Τίτλος(Asc)] Τύπος Έτος
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
R
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2020).  Renovascular Hypertension: Novel Insights.. Curr Hypertens Rev. 16(1), 24-29.
Boutari, C., Georgianou E., Sachinidis A., Katsimardou A., Christou K., Piperidou A., et al. (2019).  Renovascular Hypertension: Novel Insights:. Current Hypertension Reviews. 15,
Sarafidis, P. A., & Ruilope L. M. (2013).  Renin-angiotensin-aldosterone system blockade in hypertensive patients with chronic kidney disease.. Blood Press. 22(6), 397-8.
Mediskou, P., Yavropoulou M. P., Kotsa K., Tsekmekidou X., Psarakou-Gotzamani A., Papazisi A., et al. (2011).  The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia.. Clin Endocrinol (Oxf). 74(3), 306-11.
Imprialos, K. P., Boutari C., Stavropoulos K., Sampani E., & Karagiannis A. I. (2016).  Renin-Angiotensin System Inhibitors: Do They Have the Same Impact at All Ages?. J Clin Hypertens (Greenwich). 18(8), 828.
Georgianos, P. I., Sarafidis P. A., & Zebekakis P. E. (2014).  Renin-angiotensin system blockade and exercise-induced increase in aortic stiffness.. J Clin Hypertens (Greenwich). 16(7), 475-6.
Sarafidis, P. A., & Bakris G. L. (2014).  Renin inhibition in patients with chronic kidney disease: is it conclusively non-indicated?. J Renin Angiotensin Aldosterone Syst. 15(1), 97-8.
Huerta, A., Bomback A. S., Liakopoulos V., Palanisamy A., M Stokes B., D'Agati V. D., et al. (2012).  Renal-limited 'lupus-like' nephritis.. Nephrol Dial Transplant. 27(6), 2337-42.
Doumas, M., & Douma S. (2010).  Renal sympathetic denervation: the jury is still out.. Lancet. 376(9756), 1878-80.
Petidis, K., Anyfanti P., & Doumas M. (2011).  Renal sympathetic denervation: renal function concerns.. Hypertension. 58(4), e19; author reply e20.
Doumas, M., Faselis C., & Papademetriou V. (2011).  Renal sympathetic denervation in hypertension.. Curr Opin Nephrol Hypertens. 20(6), 647-53.
Papademetriou, V., Doumas M., & Tsioufis C. (2016).  Renal Sympathetic Denervation: Hibernation or Resurrection?. Cardiology. 135(2), 87-97.
Papademetriou, V., Doumas M., & Tsioufis K. (2011).  Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension.. Int J Hypertens. 2011, 196518.
Doumas, M., Stavropoulos K., Imprialos K. P., Athyros V. G., & Karagiannis A. (2018).  Renal sympathetic denervation: Ashes to ashes or rebirth from the ashes?. J Clin Hypertens (Greenwich). 20(4), 634-636.
Doumas, M., Faselis C., & Papademetriou V. (2010).  Renal sympathetic denervation and systemic hypertension.. Am J Cardiol. 105(4), 570-6.
Stavropoulos, K., Imprialos K. P., Athyros V. G., & Doumas M. (2018).  Renal resistive index for renovascular hypertension: In the quest of the Holy Grail.. J Clin Hypertens (Greenwich). 20(3), 589-591.
Allegaert, K., Smits A., van Donge T., van den Anker J., Sarafidis K., Levtchenko E., et al. (2020).  Renal Precision Medicine in Neonates and Acute Kidney Injury: How to Convert a Cloud of Creatinine Observations to Support Clinical Decisions.. Front Pediatr. 8, 366.
Musso, C., Liakopoulos V., Pangre N., DiTrolio J., Jauregui R., De Miguel R., et al. (2009).  Renal physiology in elderly persons with severe immobility syndrome.. Int Urol Nephrol. 41(2), 437-41.
Prassopoulos, P., & Cavouras D. (1994).  Renal parenchymal thickness in children measured by computed tomography.. Eur Urol. 25(1), 51-4.
Kastritis, E., Gavriatopoulou M., Roussou M., Migkou M., Fotiou D., Ziogas D. C., et al. (2017).  Renal outcomes in patients with AL amyloidosis: Prognostic factors, renal response and the impact of therapy.. Am J Hematol. 92(7), 632-639.
Doumas, M., Lazaridis A., & Papademetriou V. (2014).  Renal nerve ablation for resistant hypertension: the dust has not yet settled.. J Clin Hypertens (Greenwich). 16(6), 399-400.
Papademetriou, V., Rashidi A. Adel, Tsioufis C., & Doumas M. (2014).  Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.. Circulation. 129(13), 1440-51.
Papademetriou, V., Doumas M., Anyfanti P., Faselis C., Kokkinos P., & Tsioufis C. (2014).  Renal nerve ablation for hypertensive patients with chronic kidney disease.. Curr Vasc Pharmacol. 12(1), 47-54.
Raptis, V., Loutradis C., & Sarafidis P. A. (2018).  Renal injury progression in autosomal dominant polycystic kidney disease: a look beyond the cysts.. Nephrol Dial Transplant. 33(11), 1887-1895.
Cholongitas, E., Antoniadis N., Goulis I., Fouzas I., Vasiliadis T., Akriviadis E., et al. (2016).  Renal function improvement in liver transplant recipients after early everolimus conversion: A clinical practice cohort study in Spain.. Liver Transpl. 22(1), 132-3.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές